血清髓鞘碱性蛋白作为动脉瘤性蛛网膜下腔出血脑损伤标志物
104例动脉瘤破裂后24小时内行血管内治疗的SAH患者,采集156份血样(0-3天104份、4-6天32份、9-12天20份),用ELISA检测MBP。0-3天MBP在预后不良、死亡、行颅内干预及合并ICH患者中显著升高,与3个月GOS(cc=-0.42)及ICH体积(cc=0.48)相关;血管内栓塞后83%患者MBP未升高。
要点
- SAH后0-3天MBP在预后不良、死亡、颅内干预及合并ICH患者中显著升高。
- 全部完全恢复患者0-3天MBP均低于检测下限。
- 血管内动脉瘤闭塞后104例中86例(83%)MBP未升高,提示该技术安全性。
核心结论
- 动脉瘤破裂后外周血MBP浓度反映脑组织损伤严重程度(源于手术或ICH)并与治疗结局相关。
- 血管内动脉瘤闭塞后多数病例MBP未升高,提示该技术安全性。
研究设计与样本
- 104例动脉瘤破裂的SAH患者,均在破裂后24小时内接受血管内治疗。
- 共采集156份血样:SAH后0-3天104份、4-6天32份、9-12天20份。
- MBP用ELISA检测,并与入院临床状态、实验室结果、影像学表现及3个月治疗结局比较。
主要发现
- SAH后0-3天MBP在预后不良患者中显著升高(p<0.001)。
- SAH后0-3天MBP在死亡患者中显著升高(p=0.005)。
- SAH后0-3天MBP在行颅内干预患者中显著升高(p<0.001),在合并ICH患者中亦显著升高(p<0.001)。
- SAH后4-6天MBP在行颅内干预后(p=0.009)及合并ICH时(p=0.039)显著升高。
- SAH后0-3天MBP与3个月GOS(cc=-0.42)及ICH体积(cc=0.48)存在临床相关相关性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Myelin basic protein (MBP) is the second most abundant protein in central nervous system myelin. Since the 1980s, it has been regarded as a marker of brain tissue injury in both trauma and disease. There have been no recent reports regarding MBP in aneurysmal subarachnoid haemorrhage (SAH). METHODS: One hundred four SAH patients with ruptured aneurysms underwent endovascular treatment within 24 h of rupture, and 156 blood samples were collected: 104 on days 0-3, 32 on days 4-6 and 20 on days 9-12 post-SAH. MBP levels were assayed using ELISA and compared with the clinical status on admission, laboratory results, imaging findings and treatment outcome at 3 months. RESULTS: MBP levels on days 0-3 post-SAH were significantly higher among poor outcome patients (p < 0.001), non-survivors (p = 0.005), patients who underwent intracranial intervention (p < 0.001) and patients with intracerebral haemorrhage (ICH; p < 0.001). On days 4-6 post-SAH, significantly higher levels were found following intracranial intervention (p = 0.009) and ICH (p = 0.039). There was clinically relevant correlation between MBP levels on days 0-3 post-SAH and 3-month Glasgow Outcome Scale (cc = - 0.42) and also ICH volume (cc = 0.48). All patients who made a full recovery had MBP levels below detection limit on days 0-3 post-SAH. Following endovascular aneurysm occlusion, there was no increase in MBP in 86 of the 104 patients investigated (83%). CONCLUSIONS: The concentration of MBP in peripheral blood after intracranial aneurysm rupture reflects the severity of the brain tissue injury (due to surgery or ICH) and correlates with the treatment outcome. Endovascular aneurysm occlusion was not followed by a rise in MBP in most cases, suggesting the safety of this technique.
引用
- Wąsik N, Sokół B, Hołysz M, et al. Serum myelin basic protein as a marker of brain injury in aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien). 2020. PMID: 31915942. doi:10.1007/s00701-019-04185-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。